Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Nutriband Inc.
Nutriband Inc. Announces Seven-for-Six Forward Stock Split
July 27, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
July 26, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market
July 22, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares
July 15, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Tickers
NTRB
NTRBW
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
June 03, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)
May 27, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
May 20, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
May 17, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
May 11, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
NTRB
NTRBW
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
April 29, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice
February 16, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4
February 04, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office
January 28, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology
January 18, 2022
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 10, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm
January 05, 2022
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
NTRB
NTRBW
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Transdermal System" Application
December 31, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Announces $1 Million Share Repurchase Authorization
December 29, 2021
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services
December 21, 2021
From
Nutriband Inc.
Via
AccessWire
Tickers
NTRB
NTRBW
Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary
December 13, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021
December 03, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl
November 16, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
November 10, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M
October 22, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
October 12, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
Tickers
NTRB
NTRBW
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
October 04, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market
October 01, 2021
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Tickers
NTRB
NTRBW
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.